Phoenix Life Sciences International Limited. — Form D/A
Phoenix Life Sciences International Limited. of DENVER, CO, a company, filed a Form D amendment with the SEC on 2019-04-11. The offering totals $100.0M, of which $880K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-04-11
- Form: D/A
- Accession: 0001387131-19-002601
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $100.0M
- Amount sold: $880K
- Remaining: $99.1M
- Minimum investment: $50K
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-324847
Issuer
- Name: Phoenix Life Sciences International Limited.
- CIK: 0001493212
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2009
- Address: 3000 LAWRENCE STREET, DENVER, CO, 80205
- Phone: 720-699-7222
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Martin Henry Tindall | Related Person | Salt Ash, C3 |
| Martin Henry Tindall | Director | Salt Ash, C3 |
| Martin Henry Tindall | Executive Officer | Salt Ash, C3 |
| Brent Millward | Director | Edmonton, A0 |
| Brent Millward | Executive Officer | Edmonton, A0 |
Other filings by this issuer (3)
More